Tauroursodeoxycholic acid
Suppliers
Names
[ CAS No. ]:
14605-22-2
[ Name ]:
Tauroursodeoxycholic acid
[Synonym ]:
2-[[(4R)-4-[(3R,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid
3α,7β-Dihydroxy-5β-cholan-24-oic Acid N-(2-Sulfoethyl)amide Dihydrate
2-{[(3α,7β)-3,7-Dihydroxy-24-oxocholan-24-yl]amino}ethanesulfonic acid
Tauroursodeoxycholic acid sodium salt
MFCD00069496
Ethanesulfonic acid, 2-[[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-, sodium salt (1:1)
3α,7β-Dihydroxy-5β-cholan-24-oic acid N-(2-sulfoethyl)amide
Tauroursodeoxycholic acid dihydrate
Sodium tauroursodeoxycholate
Sodium 2-{[(3α,5β,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino}ethanesulfonate
Ethanesulfonic acid, 2-[[(3α,7β)-3,7-dihydroxy-24-oxocholan-24-yl]amino]-
TAUROURSODEOXYCHOLIC ACID
Chemical & Physical Properties
[ Density]:
1.2±0.1 g/cm3
[ Boiling Point ]:
496.4ºC at 760mmHg
[ Melting Point ]:
173-175°C
[ Molecular Formula ]:
C26H45NO6S
[ Molecular Weight ]:
499.70
[ Flash Point ]:
214.2ºC
[ PSA ]:
132.31000
[ LogP ]:
2.10
[ Index of Refraction ]:
1.552
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- KI7372500
- CHEMICAL NAME :
- Ethanesulfonic acid, 2-(((3-alpha,5-beta,7-beta)-3,7-dihydroxy-24-oxochola n-24-yl)amino)-
- CAS REGISTRY NUMBER :
- 14605-22-2
- LAST UPDATED :
- 199309
- DATA ITEMS CITED :
- 4
- MOLECULAR FORMULA :
- C26-H45-N-O6-S
- MOLECULAR WEIGHT :
- 499.78
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- >5 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JKXXAF Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #92-235918
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - rat
- DOSE/DURATION :
- 300 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JKXXAF Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #92-235918
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Oral
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- >6 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JKXXAF Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #92-235918
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Rodent - mouse
- DOSE/DURATION :
- 350 mg/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- JKXXAF Japanese Kokai Tokyo Koho Patents. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #92-235918
Safety Information
[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
[ Safety Phrases ]:
S22-S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
2
[ RTECS ]:
KI7372500
Articles
Fundam. Clin. Pharmacol. 29(2) , 164-77, (2015)
On account of its strong ability to become chemoresistant after a primary response to drugs, malignant melanoma (MM) remains a therapeutic challenge. This study focuses on acquired resistance to vinca...
Proc. Natl. Acad. Sci. U. S. A. 111(20) , 7421-6, (2014)
Alterations in the gastrointestinal microbiota have been implicated in obesity in mice and humans, but the key microbial functions influencing host energy metabolism and adiposity remain to be determi...
Lab. Invest. 94(12) , 1419-30, (2014)
Ulcerative colitis (UC) is characterized by increased epithelial cell death and subsequent breakdown of the intestinal epithelial barrier, which perpetuates chronic intestinal inflammation. Since feca...